Gene · 3908
Papers2,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Regulation of the cecal microbiota community and the fatty liver deposition by the addition of brewers' spent grain to feed of Landes geese. | Front Microbiol | 2022 | 36204629 | PubTator, text mining | PubMed |
| A first-in-human phase I/IIa gene transfer clinical trial for Duchenne muscular dystrophy using rAAVrh74.MCK.GALGT2. | Mol Ther Methods Clin Dev | 2022 | 36186954 | PubTator, text mining | PubMed |
| Semi-3D cultures using Laminin 221 as a coating material for human induced pluripotent stem cells. | Regen Biomater | 2022 | 36176714 | PubTator, text mining | PubMed |
| Aortic Cellular Diversity and Quantitative Genome-Wide Association Study Trait Prioritization Through Single-Nuclear RNA Sequencing of the Aneurysmal Human Aorta. | Arterioscler Thromb Vasc Biol | 2022 | 36172868 | PubTator, text mining | PubMed |
| The role of the dystrophin glycoprotein complex in muscle cell mechanotransduction. | Commun Biol | 2022 | 36168044 | PubTator, text mining | PubMed |
| The regulatory roles of T helper cells in distinct extracellular matrix characterization in breast cancer. | Front Immunol | 2022 | 36159822 | PubTator, text mining | PubMed |
| The immune subtypes and landscape of sarcomas. | BMC Immunol | 2022 | 36153483 | PubTator, text mining | PubMed |
| Expression of extracellular matrix components in the meibomian gland. | Front Med (Lausanne) | 2022 | 36148459 | PubTator, text mining | PubMed |
| Inhibition of KRAS, MEK and PI3K Demonstrate Synergistic Anti-Tumor Effects in Pancreatic Ductal Adenocarcinoma Cell Lines. | Cancers (Basel) | 2022 | 36139627 | PubTator, text mining | PubMed |
| Proteomic Analysis of Effects of Spironolactone in Heart Failure With Preserved Ejection Fraction. | Circ Heart Fail | 2022 | 36126144 | PubTator, text mining | PubMed |
| Editorial: The role of the extracellular matrix in tumor progression and therapeutic resistance. | Front Mol Biosci | 2022 | 36120554 | PubTator, text mining | PubMed |
| Induction of functional xeno-free MSCs from human iPSCs via a neural crest cell lineage. | NPJ Regen Med | 2022 | 36109564 | PubTator, text mining | PubMed |
| Comprehensive analysis of tissue proteomics in patients with papillary thyroid microcarcinoma uncovers the underlying mechanism of lymph node metastasis and its significant sex disparities. | Front Oncol | 2022 | 36106120 | PubTator, text mining | PubMed |
| The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation. | Transl Cancer Res | 2022 | 36093542 | PubTator, text mining | PubMed |
| Bibliometric and visual analysis of blood-testis barrier research. | Front Pharmacol | 2022 | 36071829 | PubTator, text mining | PubMed |
| Differences of core genes in liver fibrosis and hepatocellular carcinoma: Evidence from integrated bioinformatics and immunohistochemical analysis. | World J Gastrointest Oncol | 2022 | 36051101 | PubTator, text mining | PubMed |
| Immunofluorescence signal intensity measurements as a semi-quantitative tool to assess sarcoglycan complex expression in muscle biopsy. | Eur J Histochem | 2022 | 36047345 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Genomic Alterations in Hepatoid Adenocarcinoma of the Stomach and Identification of Clinically Actionable Alterations. | Cancers (Basel) | 2022 | 36010842 | PubTator, text mining | PubMed |
| Gq Signaling in Autophagy Control: Between Chemical and Mechanical Cues. | Antioxidants (Basel) | 2022 | 36009317 | PubTator, text mining | PubMed |
| Spectrum of Rare and Common Genetic Variants in Arrhythmogenic Cardiomyopathy Patients. | Biomolecules | 2022 | 36008935 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3908/papers?page=21